APO Research
Talk to an analyst

APO RESEARCH · REPORT

Chinese Medicine Injection for Respiratory System

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Chinese Medicine Injection for Respiratory System Market Outlook and Growth Opportunities 2026

23 December 2025194 pages

Choose your research edition.

Industry ResearchChinese Medicine Injection for Respiratory System Industry Research Report 2026125 pages · $2,950 USDIndustry Growth & TrendsGlobal Chinese Medicine Injection for Respiratory System Industry Growth and Trends Forecast to 2032100 pages · $3,450 USDMarket StructureGlobal Chinese Medicine Injection for Respiratory System Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chinese Medicine Injection for Respiratory System Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Chinese Medicine Injection for Respiratory System Market Analysis and Forecast 2026-2032197 pages · $4,950 USD

Market perspective

The global Chinese Medicine Injection for Respiratory System market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Chinese Medicine Injection for Respiratory System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Chinese Medicine Injection for Respiratory System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Chinese Medicine Injection for Respiratory System is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Chinese Medicine Injection for Respiratory System market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Chinese Medicine Injection for Respiratory System market include Jilin Jian Yisheng Pharmaceutical, Chase Sun Pharmaceutical, Shineway Pharmaceutical, Shanghai Kaibao Pharmaceutical, Linbao Pharmaceutical, Kanion Pharmaceutical, Qingfeng Pharmaceutical Group, Harbin Pharmaceutical Group and Guangzhou Baiyunshan Mingxing Pharmaceutical, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Chinese Medicine Injection for Respiratory System market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Chinese Medicine Injection for Respiratory System and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Chinese Medicine Injection for Respiratory System sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Chinese Medicine Injection for Respiratory System market size, projected growth trends, production technologies, key applications, and end-use industries.

Chinese Medicine Injection for Respiratory System Segment by Company

Jilin Jian Yisheng Pharmaceutical

Chase Sun Pharmaceutical

Shineway Pharmaceutical

Shanghai Kaibao Pharmaceutical

Linbao Pharmaceutical

Kanion Pharmaceutical

Qingfeng Pharmaceutical Group

Harbin Pharmaceutical Group

Guangzhou Baiyunshan Mingxing Pharmaceutical

Guangdong Life Strong Pharmaceutical

Chinese Medicine Injection for Respiratory System Segment by Type

Qingkailing Injection

Reduning Injection

Tanreqing Injection

Xiyanping Injection

Xuebijing Injection

Other

Chinese Medicine Injection for Respiratory System Segment by Application

Secondary Hospital

Tertiary Hospital

Other

Chinese Medicine Injection for Respiratory System Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Chinese Medicine Injection for Respiratory System status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Chinese Medicine Injection for Respiratory System market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Chinese Medicine Injection for Respiratory System significant trends, drivers, influence factors in global and regions.

6. To analyze Chinese Medicine Injection for Respiratory System competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chinese Medicine Injection for Respiratory System market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chinese Medicine Injection for Respiratory System and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chinese Medicine Injection for Respiratory System.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Chinese Medicine Injection for Respiratory System market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Chinese Medicine Injection for Respiratory System industry.

Chapter 3: Detailed analysis of Chinese Medicine Injection for Respiratory System manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Chinese Medicine Injection for Respiratory System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Chinese Medicine Injection for Respiratory System in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Chinese Medicine Injection for Respiratory System Industry Trends Table 2. Chinese Medicine Injection for Respiratory System Industry Drivers Table 3. Chinese Medicine Injection for Respiratory System Industry Opportunities and Challenges Table 4. Chinese Medicine Injection for Respiratory System Industry Restraints Table 5. Global Chinese Medicine Injection for Respiratory System Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Chinese Medicine Injection for Respiratory System Revenue Share by Company (2021-2026) Table 7. Global Chinese Medicine Injection for Respiratory System Sales Volume by Company (k units) & (2021-2026) Table 8. Global Chinese Medicine Injection for Respiratory System Sales Volume Share by Company (2021-2026) Table 9. Global Chinese Medicine Injection for Respiratory System Average Price (USD/unit) of Company (2021-2026) Table 10. Global Chinese Medicine Injection for Respiratory System Company Ranking, (2024-2026) & (USD Million) Table 11. Global Chinese Medicine Injection for Respiratory System Key Company Manufacturing Base & Headquarters Table 12. Global Chinese Medicine Injection for Respiratory System Company, Product Type & Application Table 13. Global Chinese Medicine Injection for Respiratory System Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Chinese Medicine Injection for Respiratory System by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Qingkailing Injection Table 18. Significant Companies of Reduning Injection Table 19. Significant Companies of Tanreqing Injection Table 20. Significant Companies of Xiyanping Injection Table 21. Significant Companies of Xuebijing Injection Table 22. Significant Companies of Other Table 23. Global Chinese Medicine Injection for Respiratory System Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Chinese Medicine Injection for Respiratory System Sales Volume by Type (2021-2026) & (k units) Table 25. Global Chinese Medicine Injection for Respiratory System Sales Volume by Type (2027-2032) & (k units) Table 26. Global Chinese Medicine Injection for Respiratory System Sales Volume Share by Type (2021-2026) Table 27. Global Chinese Medicine Injection for Respiratory System Sales Volume Share by Type (2027-2032) Table 28. Global Chinese Medicine Injection for Respiratory System Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Chinese Medicine Injection for Respiratory System Sales Value by Type (2021-2026) & (US$ Million) Table 30. Global Chinese Medicine Injection for Respiratory System Sales Value by Type (2027-2032) & (US$ Million) Table 31. Global Chinese Medicine Injection for Respiratory System Sales Value Share by Type (2021-2026) Table 32. Global Chinese Medicine Injection for Respiratory System Sales Value Share by Type (2027-2032) Table 33. Significant Companies of Secondary Hospital Table 34. Significant Companies of Tertiary Hospital Table 35. Significant Companies of Other Table 36. Global Chinese Medicine Injection for Respiratory System Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Chinese Medicine Injection for Respiratory System Sales Volume by Application (2021-2026) & (k units) Table 38. Global Chinese Medicine Injection for Respiratory System Sales Volume by Application (2027-2032) & (k units) Table 39. Global Chinese Medicine Injection for Respiratory System Sales Volume Share by Application (2021-2026) Table 40. Global Chinese Medicine Injection for Respiratory System Sales Volume Share by Application (2027-2032) Table 41. Global Chinese Medicine Injection for Respiratory System Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 42. Global Chinese Medicine Injection for Respiratory System Sales Value by Application (2021-2026) & (US$ Million) Table 43. Global Chinese Medicine Injection for Respiratory System Sales Value by Application (2027-2032) & (US$ Million) Table 44. Global Chinese Medicine Injection for Respiratory System Sales Value Share by Application (2021-2026) Table 45. Global Chinese Medicine Injection for Respiratory System Sales Value Share by Application (2027-2032) Table 46. Global Chinese Medicine Injection for Respiratory System Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 47. Global Chinese Medicine Injection for Respiratory System Sales by Region (2021-2026) & (k units) Table 48. Global Chinese Medicine Injection for Respiratory System Sales Market Share by Region (2021-2026) Table 49. Global Chinese Medicine Injection for Respiratory System Sales by Region (2027-2032) & (k units) Table 50. Global Chinese Medicine Injection for Respiratory System Sales Market Share by Region (2027-2032) Table 51. Global Chinese Medicine Injection for Respiratory System Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 52. Global Chinese Medicine Injection for Respiratory System Sales Value by Region (2021-2026) & (US$ Million) Table 53. Global Chinese Medicine Injection for Respiratory System Sales Value Share by Region (2021-2026) Table 54. Global Chinese Medicine Injection for Respiratory System Sales Value by Region (2027-2032) & (US$ Million) Table 55. Global Chinese Medicine Injection for Respiratory System Sales Value Share by Region (2027-2032) Table 56. Global Chinese Medicine Injection for Respiratory System Market Average Price (USD/unit) by Region (2021-2026) Table 57. Global Chinese Medicine Injection for Respiratory System Market Average Price (USD/unit) by Region (2027-2032) Table 58. Global Chinese Medicine Injection for Respiratory System Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 59. Global Chinese Medicine Injection for Respiratory System Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 60. Global Chinese Medicine Injection for Respiratory System Sales by Country (2021-2026) & (k units) Table 61. Global Chinese Medicine Injection for Respiratory System Sales Market Share by Country (2021-2026) Table 62. Global Chinese Medicine Injection for Respiratory System Sales by Country (2027-2032) & (k units) Table 63. Global Chinese Medicine Injection for Respiratory System Sales Market Share by Country (2027-2032) Table 64. Global Chinese Medicine Injection for Respiratory System Sales Value by Country (2021-2026) & (US$ Million) Table 65. Global Chinese Medicine Injection for Respiratory System Sales Value Market Share by Country (2021-2026) Table 66. Global Chinese Medicine Injection for Respiratory System Sales Value by Country (2027-2032) & (US$ Million) Table 67. Global Chinese Medicine Injection for Respiratory System Sales Value Market Share by Country (2027-2032) Table 68. Jilin Jian Yisheng Pharmaceutical Company Information Table 69. Jilin Jian Yisheng Pharmaceutical Business Overview Table 70. Jilin Jian Yisheng Pharmaceutical Chinese Medicine Injection for Respiratory System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 71. Jilin Jian Yisheng Pharmaceutical Chinese Medicine Injection for Respiratory System Product Portfolio Table 72. Jilin Jian Yisheng Pharmaceutical Recent Development Table 73. Chase Sun Pharmaceutical Company Information Table 74. Chase Sun Pharmaceutical Business Overview Table 75. Chase Sun Pharmaceutical Chinese Medicine Injection for Respiratory System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 76. Chase Sun Pharmaceutical Chinese Medicine Injection for Respiratory System Product Portfolio Table 77. Chase Sun Pharmaceutical Recent Development Table 78. Shineway Pharmaceutical Company Information Table 79. Shineway Pharmaceutical Business Overview Table 80. Shineway Pharmaceutical Chinese Medicine Injection for Respiratory System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 81. Shineway Pharmaceutical Chinese Medicine Injection for Respiratory System Product Portfolio Table 82. Shineway Pharmaceutical Recent Development Table 83. Shanghai Kaibao Pharmaceutical Company Information Table 84. Shanghai Kaibao Pharmaceutical Business Overview Table 85. Shanghai Kaibao Pharmaceutical Chinese Medicine Injection for Respiratory System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 86. Shanghai Kaibao Pharmaceutical Chinese Medicine Injection for Respiratory System Product Portfolio Table 87. Shanghai Kaibao Pharmaceutical Recent Development Table 88. Linbao Pharmaceutical Company Information Table 89. Linbao Pharmaceutical Business Overview Table 90. Linbao Pharmaceutical Chinese Medicine Injection for Respiratory System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 91. Linbao Pharmaceutical Chinese Medicine Injection for Respiratory System Product Portfolio Table 92. Linbao Pharmaceutical Recent Development Table 93. Kanion Pharmaceutical Company Information Table 94. Kanion Pharmaceutical Business Overview Table 95. Kanion Pharmaceutical Chinese Medicine Injection for Respiratory System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 96. Kanion Pharmaceutical Chinese Medicine Injection for Respiratory System Product Portfolio Table 97. Kanion Pharmaceutical Recent Development Table 98. Qingfeng Pharmaceutical Group Company Information Table 99. Qingfeng Pharmaceutical Group Business Overview Table 100. Qingfeng Pharmaceutical Group Chinese Medicine Injection for Respiratory System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 101. Qingfeng Pharmaceutical Group Chinese Medicine Injection for Respiratory System Product Portfolio Table 102. Qingfeng Pharmaceutical Group Recent Development Table 103. Harbin Pharmaceutical Group Company Information Table 104. Harbin Pharmaceutical Group Business Overview Table 105. Harbin Pharmaceutical Group Chinese Medicine Injection for Respiratory System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 106. Harbin Pharmaceutical Group Chinese Medicine Injection for Respiratory System Product Portfolio Table 107. Harbin Pharmaceutical Group Recent Development Table 108. Guangzhou Baiyunshan Mingxing Pharmaceutical Company Information Table 109. Guangzhou Baiyunshan Mingxing Pharmaceutical Business Overview Table 110. Guangzhou Baiyunshan Mingxing Pharmaceutical Chinese Medicine Injection for Respiratory System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 111. Guangzhou Baiyunshan Mingxing Pharmaceutical Chinese Medicine Injection for Respiratory System Product Portfolio Table 112. Guangzhou Baiyunshan Mingxing Pharmaceutical Recent Development Table 113. Guangdong Life Strong Pharmaceutical Company Information Table 114. Guangdong Life Strong Pharmaceutical Business Overview Table 115. Guangdong Life Strong Pharmaceutical Chinese Medicine Injection for Respiratory System Sales (k units), Value (US$ Million), Price (USD/unit) and Gross Margin (2021-2026) Table 116. Guangdong Life Strong Pharmaceutical Chinese Medicine Injection for Respiratory System Product Portfolio Table 117. Guangdong Life Strong Pharmaceutical Recent Development Table 118. Key Raw Materials Table 119. Raw Materials Key Suppliers Table 120. Chinese Medicine Injection for Respiratory System Distributors List Table 121. Chinese Medicine Injection for Respiratory System Customers List Table 122. Research Programs/Design for This Report Table 123. Authors List of This Report Table 124. Secondary Sources Table 125. Primary Sources List of Figures Figure 1. Chinese Medicine Injection for Respiratory System Product Image Figure 2. Global Chinese Medicine Injection for Respiratory System Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Chinese Medicine Injection for Respiratory System Sales Value (2021-2032) & (US$ Million) Figure 4. Global Chinese Medicine Injection for Respiratory System Sales (2021-2032) & (k units) Figure 5. Global Chinese Medicine Injection for Respiratory System Sales Average Price (USD/unit) & (2021-2032) Figure 6. Global Chinese Medicine Injection for Respiratory System Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Qingkailing Injection Image Figure 10. Reduning Injection Image Figure 11. Tanreqing Injection Image Figure 12. Xiyanping Injection Image Figure 13. Xuebijing Injection Image Figure 14. Other Image Figure 15. Global Chinese Medicine Injection for Respiratory System Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 16. Global Chinese Medicine Injection for Respiratory System Sales Volume Share 2021 VS 2025 VS 2032 Figure 17. Global Chinese Medicine Injection for Respiratory System Sales Volume Share by Type (2021-2032) Figure 18. Global Chinese Medicine Injection for Respiratory System Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Chinese Medicine Injection for Respiratory System Sales Value Share 2021 VS 2025 VS 2032 Figure 20. Global Chinese Medicine Injection for Respiratory System Sales Value Share by Type (2021-2032) Figure 21. Secondary Hospital Image Figure 22. Tertiary Hospital Image Figure 23. Other Image Figure 24. Global Chinese Medicine Injection for Respiratory System Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 25. Global Chinese Medicine Injection for Respiratory System Sales Volume Share 2021 VS 2025 VS 2032 Figure 26. Global Chinese Medicine Injection for Respiratory System Sales Volume Share by Application (2021-2032) Figure 27. Global Chinese Medicine Injection for Respiratory System Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Chinese Medicine Injection for Respiratory System Sales Value Share 2021 VS 2025 VS 2032 Figure 29. Global Chinese Medicine Injection for Respiratory System Sales Value Share by Application (2021-2032) Figure 30. Global Chinese Medicine Injection for Respiratory System Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 31. Global Chinese Medicine Injection for Respiratory System Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 32. Global Chinese Medicine Injection for Respiratory System Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 33. Global Chinese Medicine Injection for Respiratory System Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 34. North America Chinese Medicine Injection for Respiratory System Sales Value (2021-2032) & (US$ Million) Figure 35. North America Chinese Medicine Injection for Respiratory System Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Europe Chinese Medicine Injection for Respiratory System Sales Value (2021-2032) & (US$ Million) Figure 37. Europe Chinese Medicine Injection for Respiratory System Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Asia-Pacific Chinese Medicine Injection for Respiratory System Sales Value (2021-2032) & (US$ Million) Figure 39. Asia-Pacific Chinese Medicine Injection for Respiratory System Sales Value Share by Country (%), 2025 VS 2032 Figure 40. South America Chinese Medicine Injection for Respiratory System Sales Value (2021-2032) & (US$ Million) Figure 41. South America Chinese Medicine Injection for Respiratory System Sales Value Share by Country (%), 2025 VS 2032 Figure 42. Middle East & Africa Chinese Medicine Injection for Respiratory System Sales Value (2021-2032) & (US$ Million) Figure 43. Middle East & Africa Chinese Medicine Injection for Respiratory System Sales Value Share by Country (%), 2025 VS 2032 Figure 44. USA Chinese Medicine Injection for Respiratory System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. USA Chinese Medicine Injection for Respiratory System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. USA Chinese Medicine Injection for Respiratory System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Canada Chinese Medicine Injection for Respiratory System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Canada Chinese Medicine Injection for Respiratory System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Canada Chinese Medicine Injection for Respiratory System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Mexico Chinese Medicine Injection for Respiratory System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Mexico Chinese Medicine Injection for Respiratory System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Mexico Chinese Medicine Injection for Respiratory System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Germany Chinese Medicine Injection for Respiratory System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Germany Chinese Medicine Injection for Respiratory System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Germany Chinese Medicine Injection for Respiratory System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. France Chinese Medicine Injection for Respiratory System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. France Chinese Medicine Injection for Respiratory System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. France Chinese Medicine Injection for Respiratory System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. U.K. Chinese Medicine Injection for Respiratory System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. U.K. Chinese Medicine Injection for Respiratory System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. U.K. Chinese Medicine Injection for Respiratory System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Italy Chinese Medicine Injection for Respiratory System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Italy Chinese Medicine Injection for Respiratory System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Italy Chinese Medicine Injection for Respiratory System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Spain Chinese Medicine Injection for Respiratory System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Spain Chinese Medicine Injection for Respiratory System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Spain Chinese Medicine Injection for Respiratory System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Russia Chinese Medicine Injection for Respiratory System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Russia Chinese Medicine Injection for Respiratory System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Russia Chinese Medicine Injection for Respiratory System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Netherlands Chinese Medicine Injection for Respiratory System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Netherlands Chinese Medicine Injection for Respiratory System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Netherlands Chinese Medicine Injection for Respiratory System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Nordic Countries Chinese Medicine Injection for Respiratory System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Nordic Countries Chinese Medicine Injection for Respiratory System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Nordic Countries Chinese Medicine Injection for Respiratory System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. China Chinese Medicine Injection for Respiratory System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. China Chinese Medicine Injection for Respiratory System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. China Chinese Medicine Injection for Respiratory System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Japan Chinese Medicine Injection for Respiratory System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Japan Chinese Medicine Injection for Respiratory System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Japan Chinese Medicine Injection for Respiratory System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. South Korea Chinese Medicine Injection for Respiratory System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. South Korea Chinese Medicine Injection for Respiratory System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. South Korea Chinese Medicine Injection for Respiratory System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. India Chinese Medicine Injection for Respiratory System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. India Chinese Medicine Injection for Respiratory System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. India Chinese Medicine Injection for Respiratory System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Australia Chinese Medicine Injection for Respiratory System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Australia Chinese Medicine Injection for Respiratory System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Australia Chinese Medicine Injection for Respiratory System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Southeast Asia Chinese Medicine Injection for Respiratory System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Southeast Asia Chinese Medicine Injection for Respiratory System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Southeast Asia Chinese Medicine Injection for Respiratory System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Brazil Chinese Medicine Injection for Respiratory System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Brazil Chinese Medicine Injection for Respiratory System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Brazil Chinese Medicine Injection for Respiratory System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Argentina Chinese Medicine Injection for Respiratory System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Argentina Chinese Medicine Injection for Respiratory System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Argentina Chinese Medicine Injection for Respiratory System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Chile Chinese Medicine Injection for Respiratory System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Chile Chinese Medicine Injection for Respiratory System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Chile Chinese Medicine Injection for Respiratory System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Colombia Chinese Medicine Injection for Respiratory System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Colombia Chinese Medicine Injection for Respiratory System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Colombia Chinese Medicine Injection for Respiratory System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Peru Chinese Medicine Injection for Respiratory System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Peru Chinese Medicine Injection for Respiratory System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Peru Chinese Medicine Injection for Respiratory System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Saudi Arabia Chinese Medicine Injection for Respiratory System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Saudi Arabia Chinese Medicine Injection for Respiratory System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Saudi Arabia Chinese Medicine Injection for Respiratory System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Israel Chinese Medicine Injection for Respiratory System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Israel Arabia Chinese Medicine Injection for Respiratory System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Israel Arabia Chinese Medicine Injection for Respiratory System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. UAE Chinese Medicine Injection for Respiratory System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. UAE Chinese Medicine Injection for Respiratory System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. UAE Chinese Medicine Injection for Respiratory System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Turkey Chinese Medicine Injection for Respiratory System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Turkey Chinese Medicine Injection for Respiratory System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Turkey Chinese Medicine Injection for Respiratory System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Iran Chinese Medicine Injection for Respiratory System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Iran Chinese Medicine Injection for Respiratory System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Iran Chinese Medicine Injection for Respiratory System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Egypt Chinese Medicine Injection for Respiratory System Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 126. Egypt Chinese Medicine Injection for Respiratory System Sales Value Share by Type, 2025 VS 2032 & (%) Figure 127. Egypt Chinese Medicine Injection for Respiratory System Sales Value Share by Application, 2025 VS 2032 & (%) Figure 128. Chinese Medicine Injection for Respiratory System Value Chain Figure 129. Manufacturing Cost Structure Figure 130. Chinese Medicine Injection for Respiratory System Sales Mode & Process Figure 131. Direct Comparison with Distribution Share Figure 132. Distributors Profiles Figure 133. Years Considered Figure 134. Research Process Figure 135. Key Executives Interviewed

Scope & coverage.

Types
  • Qingkailing Injection
  • Reduning Injection
  • Tanreqing Injection
  • Xiyanping Injection
  • Xuebijing Injection
  • Other
Applications
  • Secondary Hospital
  • Tertiary Hospital
  • Other
Companies covered
  • Jilin Jian Yisheng Pharmaceutical
  • Chase Sun Pharmaceutical
  • Shineway Pharmaceutical
  • Shanghai Kaibao Pharmaceutical
  • Linbao Pharmaceutical
  • Kanion Pharmaceutical
  • Qingfeng Pharmaceutical Group
  • Harbin Pharmaceutical Group
  • Guangzhou Baiyunshan Mingxing Pharmaceutical
  • Guangdong Life Strong Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Chinese Medicine Injection for Respiratory System Sales Value (2021-2032)
  4. 1.2.2 Global Chinese Medicine Injection for Respiratory System Sales Volume (2021-2032)
  5. 1.2.3 Global Chinese Medicine Injection for Respiratory System Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Chinese Medicine Injection for Respiratory System Market Dynamics
  1. 2.1 Chinese Medicine Injection for Respiratory System Industry Trends
  2. 2.2 Chinese Medicine Injection for Respiratory System Industry Drivers
  3. 2.3 Chinese Medicine Injection for Respiratory System Industry Opportunities and Challenges
  4. 2.4 Chinese Medicine Injection for Respiratory System Industry Restraints
3 Chinese Medicine Injection for Respiratory System Market by Company
  1. 3.1 Global Chinese Medicine Injection for Respiratory System Company Revenue Ranking in 2025
  2. 3.2 Global Chinese Medicine Injection for Respiratory System Revenue by Company (2021-2026)
  3. 3.3 Global Chinese Medicine Injection for Respiratory System Sales Volume by Company (2021-2026)
  4. 3.4 Global Chinese Medicine Injection for Respiratory System Average Price by Company (2021-2026)
  5. 3.5 Global Chinese Medicine Injection for Respiratory System Company Ranking (2024-2026)
  6. 3.6 Global Chinese Medicine Injection for Respiratory System Company Manufacturing Base and Headquarters
  7. 3.7 Global Chinese Medicine Injection for Respiratory System Company Product Type and Application
  8. 3.8 Global Chinese Medicine Injection for Respiratory System Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Chinese Medicine Injection for Respiratory System Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Chinese Medicine Injection for Respiratory System Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Chinese Medicine Injection for Respiratory System Market by Type
  1. 4.1 Chinese Medicine Injection for Respiratory System Type Introduction
  2. 4.1.1 Qingkailing Injection
  3. 4.1.2 Reduning Injection
  4. 4.1.3 Tanreqing Injection
  5. 4.1.4 Xiyanping Injection
  6. 4.1.5 Xuebijing Injection
  7. 4.1.6 Other
  8. 4.2 Global Chinese Medicine Injection for Respiratory System Sales Volume by Type
  9. 4.2.1 Global Chinese Medicine Injection for Respiratory System Sales Volume by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Chinese Medicine Injection for Respiratory System Sales Volume by Type (2021-2032)
  11. 4.2.3 Global Chinese Medicine Injection for Respiratory System Sales Volume Share by Type (2021-2032)
  12. 4.3 Global Chinese Medicine Injection for Respiratory System Sales Value by Type
  13. 4.3.1 Global Chinese Medicine Injection for Respiratory System Sales Value by Type (2021 VS 2025 VS 2032)
  14. 4.3.2 Global Chinese Medicine Injection for Respiratory System Sales Value by Type (2021-2032)
  15. 4.3.3 Global Chinese Medicine Injection for Respiratory System Sales Value Share by Type (2021-2032)
5 Chinese Medicine Injection for Respiratory System Market by Application
  1. 5.1 Chinese Medicine Injection for Respiratory System Application Introduction
  2. 5.1.1 Secondary Hospital
  3. 5.1.2 Tertiary Hospital
  4. 5.1.3 Other
  5. 5.2 Global Chinese Medicine Injection for Respiratory System Sales Volume by Application
  6. 5.2.1 Global Chinese Medicine Injection for Respiratory System Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Chinese Medicine Injection for Respiratory System Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Chinese Medicine Injection for Respiratory System Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Chinese Medicine Injection for Respiratory System Sales Value by Application
  10. 5.3.1 Global Chinese Medicine Injection for Respiratory System Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Chinese Medicine Injection for Respiratory System Sales Value by Application (2021-2032)
  12. 5.3.3 Global Chinese Medicine Injection for Respiratory System Sales Value Share by Application (2021-2032)
6 Chinese Medicine Injection for Respiratory System Regional Sales and Value Analysis
  1. 6.1 Global Chinese Medicine Injection for Respiratory System Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Chinese Medicine Injection for Respiratory System Sales by Region (2021-2032)
  3. 6.2.1 Global Chinese Medicine Injection for Respiratory System Sales by Region: 2021-2026
  4. 6.2.2 Global Chinese Medicine Injection for Respiratory System Sales by Region (2027-2032)
  5. 6.3 Global Chinese Medicine Injection for Respiratory System Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Chinese Medicine Injection for Respiratory System Sales Value by Region (2021-2032)
  7. 6.4.1 Global Chinese Medicine Injection for Respiratory System Sales Value by Region: 2021-2026
  8. 6.4.2 Global Chinese Medicine Injection for Respiratory System Sales Value by Region (2027-2032)
  9. 6.5 Global Chinese Medicine Injection for Respiratory System Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Chinese Medicine Injection for Respiratory System Sales Value (2021-2032)
  12. 6.6.2 North America Chinese Medicine Injection for Respiratory System Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Chinese Medicine Injection for Respiratory System Sales Value (2021-2032)
  15. 6.7.2 Europe Chinese Medicine Injection for Respiratory System Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Chinese Medicine Injection for Respiratory System Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Chinese Medicine Injection for Respiratory System Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Chinese Medicine Injection for Respiratory System Sales Value (2021-2032)
  21. 6.9.2 South America Chinese Medicine Injection for Respiratory System Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Chinese Medicine Injection for Respiratory System Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Chinese Medicine Injection for Respiratory System Sales Value Share by Country, 2025 VS 2032
7 Chinese Medicine Injection for Respiratory System Country-level Sales and Value Analysis
  1. 7.1 Global Chinese Medicine Injection for Respiratory System Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Chinese Medicine Injection for Respiratory System Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Chinese Medicine Injection for Respiratory System Sales by Country (2021-2032)
  4. 7.3.1 Global Chinese Medicine Injection for Respiratory System Sales by Country (2021-2026)
  5. 7.3.2 Global Chinese Medicine Injection for Respiratory System Sales by Country (2027-2032)
  6. 7.4 Global Chinese Medicine Injection for Respiratory System Sales Value by Country (2021-2032)
  7. 7.4.1 Global Chinese Medicine Injection for Respiratory System Sales Value by Country (2021-2026)
  8. 7.4.2 Global Chinese Medicine Injection for Respiratory System Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Chinese Medicine Injection for Respiratory System Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Chinese Medicine Injection for Respiratory System Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Chinese Medicine Injection for Respiratory System Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Chinese Medicine Injection for Respiratory System Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Chinese Medicine Injection for Respiratory System Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Chinese Medicine Injection for Respiratory System Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Chinese Medicine Injection for Respiratory System Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Chinese Medicine Injection for Respiratory System Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Chinese Medicine Injection for Respiratory System Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Chinese Medicine Injection for Respiratory System Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Chinese Medicine Injection for Respiratory System Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Chinese Medicine Injection for Respiratory System Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Chinese Medicine Injection for Respiratory System Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Chinese Medicine Injection for Respiratory System Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Chinese Medicine Injection for Respiratory System Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Chinese Medicine Injection for Respiratory System Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Chinese Medicine Injection for Respiratory System Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Chinese Medicine Injection for Respiratory System Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Chinese Medicine Injection for Respiratory System Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Chinese Medicine Injection for Respiratory System Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Chinese Medicine Injection for Respiratory System Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Chinese Medicine Injection for Respiratory System Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Chinese Medicine Injection for Respiratory System Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Chinese Medicine Injection for Respiratory System Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Chinese Medicine Injection for Respiratory System Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Chinese Medicine Injection for Respiratory System Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Chinese Medicine Injection for Respiratory System Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Chinese Medicine Injection for Respiratory System Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Chinese Medicine Injection for Respiratory System Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Chinese Medicine Injection for Respiratory System Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Chinese Medicine Injection for Respiratory System Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Chinese Medicine Injection for Respiratory System Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Chinese Medicine Injection for Respiratory System Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Chinese Medicine Injection for Respiratory System Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Chinese Medicine Injection for Respiratory System Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Chinese Medicine Injection for Respiratory System Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Chinese Medicine Injection for Respiratory System Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Chinese Medicine Injection for Respiratory System Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Chinese Medicine Injection for Respiratory System Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Chinese Medicine Injection for Respiratory System Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Chinese Medicine Injection for Respiratory System Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Chinese Medicine Injection for Respiratory System Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Chinese Medicine Injection for Respiratory System Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Chinese Medicine Injection for Respiratory System Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Chinese Medicine Injection for Respiratory System Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Chinese Medicine Injection for Respiratory System Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Chinese Medicine Injection for Respiratory System Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Chinese Medicine Injection for Respiratory System Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Chinese Medicine Injection for Respiratory System Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Chinese Medicine Injection for Respiratory System Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Chinese Medicine Injection for Respiratory System Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Chinese Medicine Injection for Respiratory System Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Chinese Medicine Injection for Respiratory System Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Chinese Medicine Injection for Respiratory System Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Chinese Medicine Injection for Respiratory System Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Chinese Medicine Injection for Respiratory System Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Chinese Medicine Injection for Respiratory System Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Chinese Medicine Injection for Respiratory System Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Chinese Medicine Injection for Respiratory System Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Chinese Medicine Injection for Respiratory System Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Chinese Medicine Injection for Respiratory System Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Chinese Medicine Injection for Respiratory System Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Chinese Medicine Injection for Respiratory System Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Chinese Medicine Injection for Respiratory System Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Chinese Medicine Injection for Respiratory System Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Chinese Medicine Injection for Respiratory System Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Chinese Medicine Injection for Respiratory System Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Chinese Medicine Injection for Respiratory System Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Chinese Medicine Injection for Respiratory System Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Chinese Medicine Injection for Respiratory System Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Chinese Medicine Injection for Respiratory System Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Chinese Medicine Injection for Respiratory System Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Chinese Medicine Injection for Respiratory System Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Chinese Medicine Injection for Respiratory System Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Chinese Medicine Injection for Respiratory System Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Chinese Medicine Injection for Respiratory System Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Chinese Medicine Injection for Respiratory System Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Chinese Medicine Injection for Respiratory System Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Chinese Medicine Injection for Respiratory System Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Chinese Medicine Injection for Respiratory System Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Chinese Medicine Injection for Respiratory System Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Chinese Medicine Injection for Respiratory System Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Chinese Medicine Injection for Respiratory System Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Chinese Medicine Injection for Respiratory System Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Jilin Jian Yisheng Pharmaceutical
  2. 8.1.1 Jilin Jian Yisheng Pharmaceutical Company Information
  3. 8.1.2 Jilin Jian Yisheng Pharmaceutical Business Overview
  4. 8.1.3 Jilin Jian Yisheng Pharmaceutical Chinese Medicine Injection for Respiratory System Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Jilin Jian Yisheng Pharmaceutical Chinese Medicine Injection for Respiratory System Product Portfolio
  6. 8.1.5 Jilin Jian Yisheng Pharmaceutical Recent Developments
  7. 8.2 Chase Sun Pharmaceutical
  8. 8.2.1 Chase Sun Pharmaceutical Company Information
  9. 8.2.2 Chase Sun Pharmaceutical Business Overview
  10. 8.2.3 Chase Sun Pharmaceutical Chinese Medicine Injection for Respiratory System Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Chase Sun Pharmaceutical Chinese Medicine Injection for Respiratory System Product Portfolio
  12. 8.2.5 Chase Sun Pharmaceutical Recent Developments
  13. 8.3 Shineway Pharmaceutical
  14. 8.3.1 Shineway Pharmaceutical Company Information
  15. 8.3.2 Shineway Pharmaceutical Business Overview
  16. 8.3.3 Shineway Pharmaceutical Chinese Medicine Injection for Respiratory System Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Shineway Pharmaceutical Chinese Medicine Injection for Respiratory System Product Portfolio
  18. 8.3.5 Shineway Pharmaceutical Recent Developments
  19. 8.4 Shanghai Kaibao Pharmaceutical
  20. 8.4.1 Shanghai Kaibao Pharmaceutical Company Information
  21. 8.4.2 Shanghai Kaibao Pharmaceutical Business Overview
  22. 8.4.3 Shanghai Kaibao Pharmaceutical Chinese Medicine Injection for Respiratory System Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Shanghai Kaibao Pharmaceutical Chinese Medicine Injection for Respiratory System Product Portfolio
  24. 8.4.5 Shanghai Kaibao Pharmaceutical Recent Developments
  25. 8.5 Linbao Pharmaceutical
  26. 8.5.1 Linbao Pharmaceutical Company Information
  27. 8.5.2 Linbao Pharmaceutical Business Overview
  28. 8.5.3 Linbao Pharmaceutical Chinese Medicine Injection for Respiratory System Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Linbao Pharmaceutical Chinese Medicine Injection for Respiratory System Product Portfolio
  30. 8.5.5 Linbao Pharmaceutical Recent Developments
  31. 8.6 Kanion Pharmaceutical
  32. 8.6.1 Kanion Pharmaceutical Company Information
  33. 8.6.2 Kanion Pharmaceutical Business Overview
  34. 8.6.3 Kanion Pharmaceutical Chinese Medicine Injection for Respiratory System Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Kanion Pharmaceutical Chinese Medicine Injection for Respiratory System Product Portfolio
  36. 8.6.5 Kanion Pharmaceutical Recent Developments
  37. 8.7 Qingfeng Pharmaceutical Group
  38. 8.7.1 Qingfeng Pharmaceutical Group Company Information
  39. 8.7.2 Qingfeng Pharmaceutical Group Business Overview
  40. 8.7.3 Qingfeng Pharmaceutical Group Chinese Medicine Injection for Respiratory System Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Qingfeng Pharmaceutical Group Chinese Medicine Injection for Respiratory System Product Portfolio
  42. 8.7.5 Qingfeng Pharmaceutical Group Recent Developments
  43. 8.8 Harbin Pharmaceutical Group
  44. 8.8.1 Harbin Pharmaceutical Group Company Information
  45. 8.8.2 Harbin Pharmaceutical Group Business Overview
  46. 8.8.3 Harbin Pharmaceutical Group Chinese Medicine Injection for Respiratory System Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Harbin Pharmaceutical Group Chinese Medicine Injection for Respiratory System Product Portfolio
  48. 8.8.5 Harbin Pharmaceutical Group Recent Developments
  49. 8.9 Guangzhou Baiyunshan Mingxing Pharmaceutical
  50. 8.9.1 Guangzhou Baiyunshan Mingxing Pharmaceutical Company Information
  51. 8.9.2 Guangzhou Baiyunshan Mingxing Pharmaceutical Business Overview
  52. 8.9.3 Guangzhou Baiyunshan Mingxing Pharmaceutical Chinese Medicine Injection for Respiratory System Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Guangzhou Baiyunshan Mingxing Pharmaceutical Chinese Medicine Injection for Respiratory System Product Portfolio
  54. 8.9.5 Guangzhou Baiyunshan Mingxing Pharmaceutical Recent Developments
  55. 8.10 Guangdong Life Strong Pharmaceutical
  56. 8.10.1 Guangdong Life Strong Pharmaceutical Company Information
  57. 8.10.2 Guangdong Life Strong Pharmaceutical Business Overview
  58. 8.10.3 Guangdong Life Strong Pharmaceutical Chinese Medicine Injection for Respiratory System Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Guangdong Life Strong Pharmaceutical Chinese Medicine Injection for Respiratory System Product Portfolio
  60. 8.10.5 Guangdong Life Strong Pharmaceutical Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Chinese Medicine Injection for Respiratory System Value Chain Analysis
  2. 9.1.1 Chinese Medicine Injection for Respiratory System Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Chinese Medicine Injection for Respiratory System Sales Mode & Process
  6. 9.2 Chinese Medicine Injection for Respiratory System Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Chinese Medicine Injection for Respiratory System Distributors
  9. 9.2.3 Chinese Medicine Injection for Respiratory System Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst